Anixa Biosciences
Stock Forecast, Prediction & Price Target
Anixa Biosciences Financial Estimates
Anixa Biosciences Revenue Estimates
Anixa Biosciences EBITDA Estimates
Anixa Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 10/31/2021 | 10/31/2022 | 10/31/2023 | 10/31/2025 | 10/31/2026 | 10/31/2027 | |
Revenue
% change YoY
| $512.5K N/A | $2.46B 481656.09% | $210K -99.99% | Avg: $120M Low: $120M High: $120M avg. 57042.85% | Avg: $88.60K Low: $88.60K High: $88.60K avg. -99.92% | Avg: $34M Low: $34M High: $34M avg. 38274.28% | |
Net Income
% change YoY
| $-12.94M N/A | $-13.49M -4.20% | $-9.81M 27.27% | Avg: $-15M Low: $-13.94M High: $-13.94M avg. -52.88% | Avg: $-5.57M Low: $-5.57M High: $-5.57M avg. 62.82% | Avg: $31.28M Low: $31.28M High: $31.28M avg. 661.11% | |
EBITDA
% change YoY
| $-13.08M N/A | $-13.83M -5.74% | $-10.96M 20.73% | Avg: $-48.13M Low: $-48.13M High: $-48.13M avg. -338.98% | Avg: $-35.53K Low: $-35.53K High: $-35.53K avg. 99.92% | Avg: $-13.63M Low: $-13.63M High: $-13.63M avg. -38275.01% | |
EPS
% change YoY
| -$0.45 N/A | -$0.44 2.22% | -$0.32 27.27% | Avg: -$0.45 Low: -$0.45 High: -$0.45 avg. -40.62% | Avg: -$0.18 Low: -$0.18 High: -$0.18 avg. 60% | Avg: $1.01 Low: $1.01 High: $1.01 avg. 661.11% | |
Operating Expenses
% change YoY
| $13.26M N/A | $13.87M 4.61% | $11.06M -20.28% | Avg: $1.61B Low: $1.61B High: $1.61B avg. 14528.56% | Avg: $1.19M Low: $1.19M High: $1.19M avg. -99.92% | Avg: $458.41M Low: $458.41M High: $458.41M avg. 38274.29% | |
FAQ
What is Anixa Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 223.68% in 2025-2027.
We have gathered data from 1 analysts. Their low estimate is -13.94M, average is -15M and high is -13.94M.
What is Anixa Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 31739.07% in 2025-2027.
We have gathered data from 1 analysts. Their low revenue estimate is $120M, average is $120M and high is $120M.
What is Anixa Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 226.82% in 2025-2027.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.45, average is -$0.45 and high is $-0.45.
What is the best performing analyst?
In the last twelve months analysts have been covering Anixa Biosciences stock. The most successful analyst is Matthew Barcus.